Fuell Fluid e-Bike Ready to Ship
Holland & Knight Turns to Paladin Platform for Pro Bono Matchmaking
Dell Works with Paladin to Double Down on Pro Bono Efforts
Mymee, Inc. Expands Executive Leadership Team to Support Commercial Growth
Accelerate NY Seed fund invested $100,000 in cancer drug developer TargaGenix Inc. The company is commercializing a novel chemotherapy agent developed at Stony Brook University.
Click Here to to Read More